Adding Low-Dose Radiation Improves Survival Outcomes in Small Cell Lung Cancer

Adding low-dose radiation to the current standard first-line treatment, durvalumab plus etoposide-platinum chemotherapy, appears to improve survival outcomes in patients with extensive-stage small cell lung cancer (SCLC), suggested new findings from a small, single-arm study.

The analysis, presented at the 2024 European Lung Cancer Congress, revealed that low-dose radiation improved patients' median progression-free and overall survival compared with standard first-line treatment, The standard first-line treatment results came from the 2019 CASPIAN trial, which found that patients receiving the first-line regimen had a median progression-free survival of 5 months and a median overall survival of 13 months, with 54% of patient alive at 1 year. The latest data, which included a small cohort of 30 patients, revealed that adding low-dose radiation to the standard first-line therapy led to a higher median progression-free survival of 8.3 months and extended median overall survival beyond the study follow-up period of 17.3 months. Overall, 66% of patients were alive at 1 year. These are "promising" improvements over CASPIAN, Zhang, a lung cancer medical oncologist at Sichuan University, Chengdu, China, said at the Congress, which was organized by the European Society for Medical Oncology., PhD, MBBS, a radiation oncologist at Belfast City Hospital, Belfast, Northern Ireland, agree

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Lung screening saves lives: How Temple Lung Center is screening Philly community against lung cancerThe Temple Healthy Chest Initiative (THCI) has been educating and screening the Philadelphia community for a variety of conditions that can be detected through a simple ten-minute screening.
Source: 6abc - 🏆 250. / 63 Read more »

Your home could be putting you at risk of lung cancer, a Utah cancer expert saysOncologists like Dr. Wallace Akerley with the Huntsman Cancer Institute have their calendars full of non-smoking lung cancer patients. How can this be? The answer is simple: radon.
Source: KSLcom - 🏆 549. / 51 Read more »

AI predicted brain metastasis in lung cancer patients more accurately.Artificial intelligence deep learning predicts if a patient’s non-small cell lung cancer (NSCLC) will spread to the brain better than expert pathologists.
Source: PsychToday - 🏆 714. / 51 Read more »

Lung CancerLung cancer is diagnosed in an estimated 174,000 Americans each year. Here you'll find in-depth lung cancer information including its symptoms, stages, and treatments.
Source: WebMD - 🏆 709. / 51 Read more »

The Trojan Horse Approach – New Method Could Revolutionize Lung Cancer TreatmentScience, Space and Technology News 2024
Source: SciTechDaily1 - 🏆 84. / 68 Read more »

AI may predict spread of lung cancer to brainScientists trained a machine-learning algorithm to predict accurately brain metastasis using biopsy samples from early-stage non-small cell lung cancer patients. It was also highly accurate in predicting those patients who do not develop metastatic brain tumors.
Source: ScienceDaily - 🏆 452. / 53 Read more »